Cargando…
Real‐world data on the efficacy and safety of immune‐checkpoint inhibitors in elderly patients with non‐small cell lung cancer
PURPOSE: Immune‐checkpoint inhibitors (ICIs) are effective against advanced non‐small cell lung cancer (NSCLC). However, whether the efficacy and safety of ICI treatment in elderly patients are similar to those in younger patients is unclear. This study was designed to address this question. METHODS...
Autores principales: | Morinaga, Daisuke, Asahina, Hajime, Ito, Shotaro, Honjo, Osamu, Tanaka, Hisashi, Honda, Ryoichi, Yokouchi, Hiroshi, Nakamura, Keiichi, Takamura, Kei, Hommura, Fumihiro, Kawai, Yasutaka, Ito, Kenichiro, Sukoh, Noriaki, Yokoo, Keiki, Morita, Ryo, Harada, Toshiyuki, Takashina, Taichi, Goda, Tomohiro, Dosaka‐Akita, Hirotoshi, Isobe, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242309/ https://www.ncbi.nlm.nih.gov/pubmed/36999734 http://dx.doi.org/10.1002/cam4.5889 |
Ejemplares similares
-
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)
por: Yamamoto, Gaku, et al.
Publicado: (2021) -
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007) -
A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations
por: Asahina, H, et al.
Publicado: (2006) -
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival
por: Yokouchi, Hiroshi, et al.
Publicado: (2020) -
Prognostic significance of OX40(+) lymphocytes in tumor stroma of surgically resected small-cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2021)